namuscla
lupin europe gmbh - mexiletine hydrochloride - Миотонических poremećaja - srčana terapija - namuscla indiciran za simptomatsko liječenje миотонии u odraslih bolesnika s non-дистрофические миотонических poremećaja.
talzenna
pfizer europe ma eeig - talazoparib - neoplazme dojki - antineoplastična sredstva - talzenna prikazan kao monoterapija za liječenje odraslih bolesnika s зародышевой linije gena brca1/2 mutacije, koje imaju her2 negativan lokalno-održao ili метастатического raka dojke . patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. pacijenti s receptore hormona (h)-pozitivan rak dojke moraju biti obrađene do эндокринно-terapija, ili se smatraju neprikladnim za endokrine terapije na temelju.
xospata
astellas pharma europe b.v. - gilteritinib фумарат - leukemija, mieloidna, akutna - antineoplastična sredstva - xospata prikazan kao monoterapija za liječenje odraslih pacijenata s relaps ili vatrostalne akutne mijeloične leukemije (aml) s перегласовкой flt3 na .
grilif 500 mg/1 kapsula+ 10 mg/1 kapsula+ 4 mg/1 kapsula kapsula, tvrda
salvus bh d.o.o. - fenilefrin, hlorfenamin, paracetamol - kapsula, tvrda - 500 mg/1 kapsula+ 10 mg/1 kapsula+ 4 mg/1 kapsula - 1 kapsula, tvrda sadrži: 500 mg paracetamola 10 mg fenilefrin hidroklorida 4 mg klorfenamin maleata
digoxin sopharma 0.25 mg/1 ml otopina za injekciju
unifarm d.o.o. lukavac - digoksin - otopina za injekciju - 0.25 mg/1 ml - 1 ml otopine za injekciju sadrži: 0,25 mg digoksina
fampridine accord
accord healthcare s.l.u. - fampridine - multipla skleroza - ostali lijekovi protiv živčanog sustava - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - uterusa - hipofiza i hipotalamusni hormoni i analozi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
fampridin teva 10 mg tablete s produljenim oslobađanjem
teva gmbh, graf-arco-str. 3, ulm, njemačka - fampridin - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 10 mg fampridina
lanibos 0.25 mg/1 tableta tableta
bosnalijek d.d. - digoksin - tableta - 0.25 mg/1 tableta - 1 tableta sadrži: 0,25 mg digoksin